Marketing and manufacturing practices for compounded GLP-1RA drugs have come under FDA scrutiny, prompting policy changes.

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have garnered significant attention recently, both in the media and in ...

In this cohort study, 40% of orders for glucagon-like peptide-1 receptor agonists (GLP-1RAs) were not filled. Non-Hispanic Black patients and Hispanic patients were less likely to fill orders than non ...

Discover how FTIR spectroscopy enhances quality control in GLP-1 weight loss drug production by ensuring molecular ...

Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...

The use of GLP-1RAs may improve RA disease activity and cardiovascular risk profiles among patients with overweight or obesity.

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in ...

Novo Nordisk has agreed to buy Akero Therapeutics in a deal rising to a potential $5.2bn, as the Danish drugmaker looks to ...

Physicians Face Telehealth Woes Amid Federal Government Shutdown As federal waivers expanding telehealth access for Medicare patients ended with the federal government shutdown, physicians are ...